linolenyl alcohol: RN given refers to (Z,Z,Z)-isomer
(9Z,12Z,15Z)-octadecatrien-1-ol : A long chain fatty primary alcohol that is octadecanol containing three double bonds located at positions 9, 12 and 15.
ID Source | ID |
---|---|
PubMed CID | 6436081 |
CHEBI ID | 77474 |
SCHEMBL ID | 59807 |
MeSH ID | M0114469 |
Synonym |
---|
506-44-5 |
(9z,12z,15z)-9,12,15-octadecatrien-1-ol |
linolenyl alcohol |
(9z,12z,15z)-octadeca-9,12,15-trien-1-ol |
einecs 208-039-7 |
yc8dmo65r7 , |
unii-yc8dmo65r7 |
9,12,15-octadecatrien-1-ol, (9z,12z,15z)- |
SCHEMBL59807 |
linolenic alcohol |
(z,z,z)-9,12,15-octadecatrien-1-ol |
all-cis-9,12,15-octadecatrien-1-ol |
cis,cis,cis-9,12,15-octadecatrien-1-ol |
9,12,15-octadecatrien-1-ol, (z,z,z)- |
linolenyl alcohol [usp-rs] |
cis,cis,cis-9,12,15-octadecatrienol |
(9z,12z,15z)-octadecatrienyl alcohol |
(9z,12z,15z)-1-octadecatrienol |
(9z,12z,15z)-octadecatrien-1-ol |
CHEBI:77474 |
(9e,12e,15e)-9,12,15-octadecatrien-1-ol # |
Q27147009 |
DTXSID80880766 |
Excerpt | Reference | Relevance |
---|---|---|
"Linolenyl alcohol has been shown to inhibit the in vitro growth of several species of gram-positive bacteria. " | ( Use of lipids to potentiate the antibacterial activity of aminoglycosides. Connamacher, R; Gilbertson, JR; Langkamp, HH; Platt, D, 1984) | 1.71 |
Role | Description |
---|---|
antibacterial agent | A substance (or active part thereof) that kills or slows the growth of bacteria. |
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] |
Class | Description |
---|---|
long-chain primary fatty alcohol | A long-chain fatty alcohol in which the hydroxy group is attached to a methylene (CH2) group. |
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 3 (60.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (20.00) | 29.6817 |
2010's | 1 (20.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
| This Compound (23.12) All Compounds (24.57) |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 5 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |